Third Rock Ventures II, L.P.
CIK 1488495 · last filed 2021-05-27
Third Rock Ventures II, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing shows the insider sold $26.5M of JNCE on May 27, 2021. Across all open-market trades the lifetime net is −$26.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
3
-$26.52M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. (JNCE) Delisted | 10%+ Owner | 8,996,609 | $1.88 | $16.91M | -$26.52M | 1 | 2021-05-27 |
| Blueprint Medicines Corp (BPMC) Delisted | 10%+ Owner | 6,653,753 | $129.46 | $861.39M | $0 | 1 | 2015-11-18 |
| Sage Therapeutics, Inc. (SAGE) Delisted | 10%+ Owner | 11,587,296 | $8.68 | $100.58M | $0 | 1 | 2014-07-23 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-27 | Jounce Therapeutics, Inc. (JNCE) Delisted | Sell (S) | −3,315,120 | -$26.52M | EDGAR |
| 2015-11-18 | Blueprint Medicines Corp (BPMC) Delisted | Other (J) | −3,710,616 | $0 | EDGAR |
| 2014-07-23 | Sage Therapeutics, Inc. (SAGE) Delisted | Conv (C) | +56,024,095 | $0 | EDGAR |